PA
RVMD icon

Perceptive Advisors’s Revolution Medicines RVMD Stock Holding History

Perceptive Advisors’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$98.8M Buy
527,600
+269,000
+104% +$39.3M 1.48% 24
2026
Q1 		$25.1M Buy
+258,600
New +$26.1M 0.49% 45
2024
Q2 		– Sell
-618,885
Closed -$19.9M – 126
2024
Q1 		$19.9M Sell
618,885
-199,997
-24% -$5.93M 0.35% 62
2023
Q4 		$23.5M Sell
818,882
-502,913
-38% -$12.1M 0.52% 47
2023
Q3 		$36.6M Buy
+1,321,795
New +$39.2M 1.22% 26
2022
Q4 		– Sell
-310,500
Closed -$6.12M – 108
2022
Q3 		$6.12M Buy
+310,500
New +$6.82M 0.18% 77
2021
Q1 		– Sell
-224,224
Closed -$8.88M – 159
2020
Q4 		$8.88M Hold
224,224
– – 0.1% 109
2020
Q3 		$7.8M Sell
224,224
-125,776
-36% -$3.48M 0.11% 98
2020
Q2 		$11.1M Hold
350,000
– – 0.18% 78
2020
Q1 		$7.82M Buy
+350,000
New +$9.69M 0.2% 66

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Perceptive Advisors's RVMD Position: Q2 2026 in Review

Perceptive Advisors increased its Revolution Medicines (RVMD) stake by 104% in Q2 2026, buying an estimated $39.3M and bringing the position to 527,600 shares worth $98.8M. The position accounts for 1.48% of the portfolio, ranked #24.

Perceptive Advisors first reported a position in RVMD in Q1 2020 and has held it in 10 quarters since. 690 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Perceptive Advisors held 527,600 shares of Revolution Medicines worth $98.8M as of Q2 2026.
  • Perceptive Advisors bought 269,000 Revolution Medicines shares in Q2 2026, an estimated $39.3M.
  • Revolution Medicines made up 1.48% of Perceptive Advisors's portfolio in Q2 2026, its #24 holding.
  • Perceptive Advisors first reported a position in Revolution Medicines in Q1 2020 and has held it in 10 quarters since.
  • 690 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Perceptive Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.